跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Irinovid - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Irinovid
Approved
STANDARD
Irinovid
Qilu Pharmaceutical (Hainan) Co., Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
5ab751518bfb699f
Company
Qilu Pharmaceutical (Hainan) Co., Ltd.
Type
Standard
Approval Details
Approval Id
5ab751518bfb699f
Drug Approval Philippines Name
Irinovid
Product Name
Irinovid
Registration Number
DR-XY46926
Brand Name
Irinovid
Generic Name
Irinotecan Hydrochloride Trihydrate
Dosage Form
Concentrate Solution for I.V. Infusion
Dosage Strength
20mg/Ml (40mg/2mL and 100mg/5mL)
Manufacturer
Qilu Pharmaceutical (Hainan) Co., Ltd.
Importer
Hovid, Inc.
Distributor
Hovid, Inc.
Company Detail Path
/organization/qilu-pharmaceutical-hainan-co-ltd
Issuance Date
30 January 2025
Expiry Date
29 June 2030
Pharmacologic Category
Antineoplastic
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
5ab751518bfb699f
Type
Standard
Back to Philippines FDA Approvals